bioMérieux: FDA 510(k) clearances across all its applicant names

FDA lists 416 510(k) clearances, 4 PMA and 7 De Novo decisions across the 10 applicant names Caduvo groups under bioMérieux, first 1978, latest 2026. Median 510(k) review time across these names: 82 days. Since 2017 the median was 90 days, against 94 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

510(k) clearances per year

YearClearancesMedian review days
201212206
20131498
20144152
20157113
20161289
20171890
20188122
20191480
2020781
20218222
202212189
20231398
20241087
2025790
20261389

The 10 FDA applicant names in this group

Applicant name510(k) clearancesPMADe NovoYears
bioMerieux, Inc.261311983–2026
Biomerieux Vitek, Inc.49101992–1998
Vitek Systems, Inc.39001978–1993
Biofire Diagnostics, LLC26042015–2026
Biomerieux S.A.16002011–2025
Biofire Defense, LLC9022017–2026
Biofire Diagnostics, Inc.8002013–2026
Biomérieux SA4002020–2026
Ab Biomerieux2002009–2010
Biofire Diagnostics, LLC (Biomerieux)2002024–2024

Review time against the same product codes

Since 2017, 510(k)s cleared under these names took a median 90 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 94 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
LONSystem, Test, Automated, Antimicrobial Susceptibility, Short Incubation120120
JWYManual Antimicrobial Susceptibility Test Systems1919
JSJCulture Media, Selective And Non-Differential1818
JSGCulture Media, Non-Selective And Non-Differential1313
JSHCulture Media, Non-Selective And Differential1212
MDBSystem, Blood Culturing1212
JSICulture Media, Selective And Differential1111
NGZSusceptibility Test Plate, Antifungal1111
JSFCulture Media, Single Biochemical Test77
PCHGastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System77

Plus 116 more product codes.

Review panels

Most recent bioMérieux 510(k) clearances

510(k)DeviceApplicant nameProduct codeDecision dateReview days
K262172BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel; BIOFIRE FILMARRAY Gastrointestinal 1.1 (GI1.1) Panel MidBiofire Diagnostics, LLCPCH2026-11-06133
K262842BioFire Warrior Panel Control KitBiofire Defense, LLCPMN2026-11-0484
K262807VITEK 2 AST-Gram Negative Polymyxin B (<= 0.25 – >=16µg/mL);VITEK 2 AST-Gram Negative Imipenem (<= 0.25 – >=16µg/mL);VITEK 2 AST-Gram Negative Ceftazidime Avibactam (<= 0.125 – >=16µg/mL)bioMerieux, Inc.LON2026-11-0489
K262683VITEK PRObioMerieux, Inc.LON2026-11-0395
K262136BIOFIRE SPOTFIRE Vaginitis (VG) PanelBiofire Diagnostics, LLCPQA2026-10-21118
K260283VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL)bioMerieux, Inc.LON2026-10-01245
K260619VITEK 2 AST-Streptococcus Cefepime (<=0.06 – >=4 µg/mL)bioMerieux, Inc.LON2026-09-28215
K263054BIOFIRE Respiratory Panel 2.1 (RP2.1)Biofire Diagnostics, Inc.QOF2026-09-2221
K261475BIOFIRE® FILMARRAY® Tropical Fever Panel Control KitBiofire Defense, LLCPMN2026-07-1773
K260160VITEK REVEAL GN AST Assay and VITEK REVEAL AST SystembioMerieux, Inc.SAN2026-07-08169

406 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN200066De NovoOrthopedic Infection Microbial Multiplex Nucleic Acid Detection System2022-04-29
DEN200031De NovoMulti-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents2021-03-17
DEN200043De NovoDevice To Detect And Identify Selected Microbial Agents That Cause Acute Febrile Illness2020-11-20
DEN170017De NovoMers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System2017-11-24
DEN160048De Novo2017-02-14

Recalls

682 product recalls in 152 recall events under these names; 137 initiated in the last five years.

5 product recalls in 5 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 2 initiated in the last five years. Most often: Biofire Defense (4), Biomerieux France Chemin De L'Or (1).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

ClinicalTrials.gov lists 6 device studies (0 active or recruiting) with an industry lead sponsor under the 3 sponsor names below. Most recent:

Lead sponsor name on ClinicalTrials.govDevice studies
BioMérieux3
BioFire Diagnostics, LLC2
BioFire Defense LLC1

Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.

How this group is built

Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

Vitek Systems (1988), Organon Teknika's diagnostics business (2001; the ORGANON TEKNIKA names are left out because that company also had other lines), BioFire (2014). Includes filings made before each acquisition. Left out: ORGANON (plain), which is a different, pharma-related applicant.

Sources

Frequently asked questions

How many FDA 510(k) clearances are listed across bioMérieux's applicant names?

FDA lists 416 510(k) clearances, 4 PMA and 7 De Novo decisions across the 10 applicant names Caduvo groups under bioMérieux, first 1978, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.

Which FDA applicant names does bioMérieux file under?

The names with the most 510(k) clearances in this group are bioMerieux, Inc. (261); Biomerieux Vitek, Inc. (49); Vitek Systems, Inc. (39); Biofire Diagnostics, LLC (26); Biomerieux S.A. (16). The full list of 10 names is on this page.

How long does FDA take to clear bioMérieux 510(k)s?

The median time from FDA receipt to decision across 510(k)s cleared under these names is 82 days. Since 2017 the median was 90 days, against 94 days for all cleared 510(k)s in the same product codes.

Does the bioMérieux count include acquired companies?

Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.

How many device clinical trials does bioMérieux sponsor?

ClinicalTrials.gov lists 6 device studies (0 active or recruiting) with an industry lead sponsor under 3 sponsor names Caduvo groups under bioMérieux. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.

All parent companies · FDA device companies by applicant name · FDA product code lookup